Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity-Reference-Cited by-同舟云学术

Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity

Published:2011-10-18 Issue:4 Volume:26 Page:633-643
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Grkovic L,Baird K,Steinberg S M,Williams K M,Pulanic D,Cowen E W,Mitchell S A,Hakim F T,Martires K J,Avila D N,Taylor T N,Salit R B,Rowley S D,Zhang D,Fowler D H,Bishop M R,Gress R E,Pavletic S Z

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2011254.pdf

Reference51 articles.

1. Weisdorf DJ . Chronic graft-versus-host disease: where is promise for the future? Leukemia 2005; 19: 1532–1535.

2. Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood 2002; 100: 406–414.

3. Thepot S, Zhou J, Perrot A, Robin M, Xhaard A, de Latour RP et al. The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation. Leukemia 2010; 24: 1852–1858.

4. Vogelsang G, Pavletic S . Clinical manifestations and natural history. In: Flowers M, Vogelsang G (eds). Chronic Graft Versus Host Disease Interdisciplinary Management. Cambrige University Press: New York, NY, 2009, pp 56–69.

5. Cho BS, Min CK, Eom KS, Kim YJ, Kim HJ, Lee S et al. Feasibility of NIH consensus criteria for chronic graft-versus-host disease. Leukemia 2009; 23: 78–84.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of Hematological Markers in Head and Neck Cancer Patients With a History of Hematological Malignancy;Korean Journal of Otorhinolaryngology-Head and Neck Surgery;2023-10-21

2. Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effect;Blood;2023-09-14

3. Metabolic syndrome prevalence and impact on outcomes in patients with chronic graft-versus-host disease;Bone Marrow Transplantation;2023-09-08

4. Can NLR be a biomarker for mucositis and gvhd in patients undergoing allogeneic HSCT?;Brazilian Journal of Oral Sciences;2023-08-25

5. Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease;Haematologica;2023-08-16